Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pieter de Heer"'
Autor:
Wilma E. Mesker, Jan M. C. Junggeburt, Karoly Szuhai, Pieter de Heer, Hans Morreau, Hans J. Tanke, Rob A. E. M. Tollenaar
Publikováno v:
Cellular Oncology, Vol 29, Iss 5, Pp 387-398 (2007)
Background: Tumor staging insufficiently discriminates between colon cancer patients with poor and better prognosis. We have evaluated, for the primary tumor, if the carcinoma-percentage (CP), as a derivative from the carcinoma-stromal ratio, can be
Externí odkaz:
https://doaj.org/article/9794d9208f9941eba4cea288dcb2f723
Autor:
CHARLOTTE MARGARETA BRINCH, NINNA AGGERHOLM-PEDERSEN, TIM SVENSTRUP POULSEN, WOJCIECH SKOVRIDER-RUMINSKI, PIETER DE HEER, LUIT PENNINGA, ANDERS KRARUP-HANSEN, ESTRID HOGDALL
Publikováno v:
Brinch, C M, Aggerholm-Pedersen, N, Poulsen, T S, Skovrider-Ruminski, W, DE Heer, P, Penninga, L, Krarup-Hansen, A & Hogdall, E 2022, ' Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour-A Methodological Assessment Study ', Anticancer Research, vol. 42, no. 11, pp. 5527-5537 . https://doi.org/10.21873/anticanres.16022
BACKGROUND/AIM: Gastrointestinal stromal tumours (GISTs) harbour genetic aberrations in receptor tyrosine kinase KIT (KIT) or platelet-derived growth factor receptor A (PDGFRA) in 85-90% of the patients. Circulating tumour DNA (ctDNA) is a potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135ec9b3db6a677d95e3e19bb063bf19
https://doi.org/10.21873/anticanres.16022
https://doi.org/10.21873/anticanres.16022
Autor:
CHARLOTTE M. BRINCH, ESTRID HOGDALL, PIETER DE HEER, LUIT PENNINGA, RIKKE BÆK, MALENE M. JORGENSEN, BODIL E. ENGELMANN, PHILIP B. ROSSEN, HELENE J. MORTENSEN, ANDERS KRARUP-HANSEN, NINNA AGGERHOLM-PEDERSEN
Publikováno v:
Brinch, C M, Hogdall, E, Heer, P D, Penninga, L, Bæk, R, Jorgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal Tumor ', Anticancer Research, vol. 42, no. 12, pp. 5699-5717 . https://doi.org/10.21873/anticanres.16078
Brinch, C M, Høgdall, E, Heer, P D, Penninga, L, Bæk, R, Jørgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients with Gastrointestinal Stromal Tumour ', CTOS Annual meeting, Vancouver, Canada, 16/11/2022-19/11/2022 .
Brinch, C M, Hogdall, E, de Heer, P, Penninga, L, Bæk, R, Jorgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal Tumor ', Anticancer Research, vol. 42, no. 12, pp. 5699-5717 . https://doi.org/10.21873/anticanres.16078
Brinch, C M, Hogdall, E, Heer, P DE, Penninga, L, Bæk, R, Jorgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal Tumor ', Anticancer Research, vol. 42, no. 12, pp. 5699-5717 . https://doi.org/10.21873/anticanres.16078
Brinch, C M, Høgdall, E, Heer, P D, Penninga, L, Bæk, R, Jørgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients with Gastrointestinal Stromal Tumour ', CTOS Annual meeting, Vancouver, Canada, 16/11/2022-19/11/2022 .
Brinch, C M, Hogdall, E, de Heer, P, Penninga, L, Bæk, R, Jorgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal Tumor ', Anticancer Research, vol. 42, no. 12, pp. 5699-5717 . https://doi.org/10.21873/anticanres.16078
Brinch, C M, Hogdall, E, Heer, P DE, Penninga, L, Bæk, R, Jorgensen, M M, Engelmann, B E, Rossen, P B, Mortensen, H J, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Small Extracellular Vesicles' Phenotype in Patients With Gastrointestinal Stromal Tumor ', Anticancer Research, vol. 42, no. 12, pp. 5699-5717 . https://doi.org/10.21873/anticanres.16078
BACKGROUND/AIM: For patients with local gastrointestinal stromal tumor (GIST), risk stratification is used to assess the prognosis and identify patients to offer adjuvant treatment. For patients with advanced or metastatic GIST, no such risk stratifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad0ae867d22c623b06e1bf211b9410c6
https://vbn.aau.dk/ws/files/505363270/Brinch_et_al._2022_._The_Prognostic_Value_of_Plasma_Small_Extracellular_Vesicles_Phenotype_in_Patients_With_Gastrointestinal_Stromal_Tumor.pdf
https://vbn.aau.dk/ws/files/505363270/Brinch_et_al._2022_._The_Prognostic_Value_of_Plasma_Small_Extracellular_Vesicles_Phenotype_in_Patients_With_Gastrointestinal_Stromal_Tumor.pdf
Autor:
Charlotte Margareta Brinch, Estrid Hogdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 5753
Brinch, C M, Hogdall, E, Junker, N, Moeller, H J, Sandfeld-Paulsen, B, de Heer, P, Penninga, L, Rossen, P B, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor ', Cancers, vol. 14, no. 23, 5753 . https://doi.org/10.3390/cancers14235753
Brinch, C M, Hogdall, E, Junker, N, Moeller, H J, Sandfeld-Paulsen, B, de Heer, P, Penninga, L, Rossen, P B, Krarup-Hansen, A & Aggerholm-Pedersen, N 2022, ' The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor ', Cancers, vol. 14, no. 23, 5753 . https://doi.org/10.3390/cancers14235753
Background: This study investigates the prognostic value of plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) concentrations in patients with Gastrointestinal Stromal Tumor (GIST). Methods: Patients with GIST were include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7611040e026ec78cac092c3089c517e
https://pubmed.ncbi.nlm.nih.gov/36497235
https://pubmed.ncbi.nlm.nih.gov/36497235
Autor:
Niclas, Dohrn, Pieter, de Heer, Stefan Kobbelgaard, Burgdorf, Kristian Kiim, Jensen, Mads Falk, Klein, Ismail, Gögenur
Publikováno v:
Ugeskrift for laeger. 184(36)
High-level evidence now strongly supports the use of a minimally invasive approach in most abdominal surgical procedures. Minimally invasive surgery is performed with either a laparoscopic or a robotic approach, and the robotic approach has been impl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e86d7c259aae74e33baa945a06f444ef
https://pubmed.ncbi.nlm.nih.gov/36065870
https://pubmed.ncbi.nlm.nih.gov/36065870
Autor:
Pieter de Heer, Lars Bo Svendsen, Anita Herrstedt, Casper Simonsen, Jesper Christensen, Charlotte Egeland, Øivind Midttun, Per Magne Ueland, Bente Klarlund Pedersen, Anna Sundberg, Marie Lund Bay, Pernille Hojman, Sissal S. Djurhuus, Sarah Thorsen-Streit
Publikováno v:
Acta oncologica (Stockholm, Sweden). 58(5)
Background: Exercise may improve depression in cancer patients, yet the molecular mechanism behind this protection is poorly understood. Here, we aimed to explore the link between exercise and regu...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80392db5826fb2f94df2a604b831c6fc
https://pubmed.ncbi.nlm.nih.gov/30973287
https://pubmed.ncbi.nlm.nih.gov/30973287
Autor:
Casper Simonsen, Lars Bo Svendsen, Eik Bjerre, Pieter de Heer, Pernille Hojman, Jesper Christensen, Charlotte Suetta, Bente Klarlund Pedersen
Publikováno v:
Annals of surgery. 268(1)
The aim of the study was to evaluate sarcopenia as a predictor of postoperative risk of major and total complications after surgery for gastrointestinal cancer.Sarcopenia is associated with poor survival in gastrointestinal cancer patients, but the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05eb5e1108ce07139d2dc89413307dce
https://pubmed.ncbi.nlm.nih.gov/30138166
https://pubmed.ncbi.nlm.nih.gov/30138166
Autor:
Pieter de Heer, Thomas S. Kristensen, Steen C. Kofoed, Anna Banck-Petersen, Bente Klarlund Pedersen, Caper Simonsen, Jesper Christensen, Rajendra Singh Garbyal, Lars Bo Svendsen, Pernille Hojman
Publikováno v:
Diseases of the Esophagus. 31:127-128
Background Neoadjuvant chemo- or chemo-radiotherapy before tumor resection is first-line treatment in patients with GEJ but associated with considerable symptom burden and complication risk which may impair treatment efficacy and quality of life. Str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3aacb4014478080aae8e4de8781796c
https://doi.org/10.1093/dote/doy089.ps02.027
https://doi.org/10.1093/dote/doy089.ps02.027
Autor:
Steen C. Kofoed, Frederik Helgstrand, Lone Susanne Jensen, Michael Patrick Achiam, Lars Bo Svendsen, Pieter de Heer, Dan Calatayud
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 150(1)
Objective Intrathoracic anastomotic leakage after intended curative resection for cancer in the esophagus or gastroesophageal junction has a negative impact on long-term survival. The aim of this study was to investigate whether an anastomotic leakag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08720f006d1325d4ec6094a7ea4ae000
https://pubmed.ncbi.nlm.nih.gov/26126458
https://pubmed.ncbi.nlm.nih.gov/26126458
Autor:
Michiel F.G. de Maat, Cornelis J.H. van de Velde, Naoyuki Umetani, Pieter de Heer, Hein Putter, Anneke Q. van Hoesel, Gerrit A. Meijer, Nicole C. van Grieken, Peter J.K. Kuppen, Anton J. Bilchik, Rob A.E.M. Tollenaar, Dave S.B. Hoon
Publikováno v:
Journal of Clinical Oncology, 25(31), 4887-4894. American Society of Clinical Oncology
De Maat, M F G, Van De Velde, C J H, Umetani, N, De Heer, P, Putter, H, Van Hoesel, A Q, Meijer, G A, Van Grieken, N C, Kuppen, P J K, Bilchik, A J, Tollenaar, R A E M & Hoon, D S B 2007, ' Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer ', Journal of Clinical Oncology, vol. 25, no. 31, pp. 4887-4894 . https://doi.org/10.1200/JCO.2006.09.8921
De Maat, M F G, Van De Velde, C J H, Umetani, N, De Heer, P, Putter, H, Van Hoesel, A Q, Meijer, G A, Van Grieken, N C, Kuppen, P J K, Bilchik, A J, Tollenaar, R A E M & Hoon, D S B 2007, ' Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer ', Journal of Clinical Oncology, vol. 25, no. 31, pp. 4887-4894 . https://doi.org/10.1200/JCO.2006.09.8921
Purpose Overexpression of cyclooxygenase-2 (COX-2) in gastric cancer has been shown to enhance tumor progression. We investigated whether silencing by promoter region hypermethylation of the COX-2 gene contributes to disease outcome in gastric cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeb4e77d3833d57bc6beb4b3564156ab
https://research.vumc.nl/en/publications/bb547781-48b7-48a0-bcb2-e11d85c06cdb
https://research.vumc.nl/en/publications/bb547781-48b7-48a0-bcb2-e11d85c06cdb